Assessing and Managing DILI Risk in Trials: A Consultant’s Perspective
Keywords: drug induced liver injury (DILI), hepatotoxic potential, hepatotoxicity, liver dysfunction, liver injurySoftware: DILIsym®Conference: DILIDivision: DILIsym Services
Thoughts on the New Guidance
1). Define “signatures of DILI”
2). Encourage mechanistic research
3). Encourage novel use of DILI biomarkers and eDISH
US FDA & AASLD DILI Conference at the University of Maryland University College May 7-8, 2019
By Paul B Watkins
